This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Diabetes
Diabetes
Boehringer Ingelheim and Eli Lilly announce data on diabetes portfolio
Data shows that IDegLira improves glycaemic control in type 2 diabetes
OZURDEX® authorised for use in the EU for DMO
Takeda to submit data for pioglitazone containing medicines including ACTOS
Data demonstrates ‘efficacy and tolerability’ of IDegLira
CHMP positive opinion for Xultophy?
Basal insulin Toujeo® New Drug Application accepted
NICE issues positive final guidance for INVOKANA®
Jardiance add-on therapy ‘significantly reduced blood glucose and body weight’
Sanofi reports positive phase 3 results for Toujeo®
Early conversations crucial in management of type 2 diabetes
More than 40 diabetes presentations from Boehringer Ingelheim, Eli Lilly and Company Alliance
« Previous
1
…
3
4
5
6
7
…
26
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: